[1]	田欣, 姬林娟, 高旺, 等. 中医药介导的铁死亡在阿霉素所致心脏毒性中的作用机制[J]. 生命的化学, 2024, 44(5):884-889.DOI:10.13488/j.smhx.20230933. Cited in this article [1]

[2]	Zhang H, Xu A, Sun X, et al. Self-maintenance of cardiac resident reparative macrophages attenuates doxorubicin-induced cardiomyopathy through the SR-A1-c-Myc axis[J]. Circ Res, 2020, 127(5):610-627.DOI:10.1161/CIRCRESAHA.119.316428. Cited in this article [1]

[3]	Zhang Y, Ni L, Lin B, et al. SNX17 protects the heart from doxorubicin-induced cardiotoxicity by modulating LMOD2 degradation[J]. Pharmacol Res, 2021, 169:105642.DOI:10.1016/j.phrs.2021.105642. Cited in this article [1]

[4]	Li D, Yang Y, Wang S, et al. Role of acetylation in doxorubicin-induced cardiotoxicity[J]. Redox Biol, 2021, 46:102089.DOI:10.1016/j.redox.2021.102089. Cited in this article [1]

[5]

Shati AA, El-Kott AF. Acylated ghrelin prevents doxorubicin-induced cardiac intrinsic cell death and fibrosis in rats by restoring IL-6/JAK2/STAT3 signaling pathway and inhibition of STAT1[J]. Naunyn Schmiedebergs Arch Pharmacol, 2019, 392(9):1151-1168.DOI:10.1007/s00210-019-01664-9. Cited in this article [1]

[6]	Whelan RS, Konstantinidis K, Wei AC, et al. Bax regulates primary necrosis through mitochondrial dynamics[J]. Proc Natl Acad Sci U S A, 2012, 109(17):6566-6571.DOI:10.1073/pnas.1201608109. Cited in this article [1]

[7]	Xie L, Xue F, Cheng C, et al. Cardiomyocyte-specific knockout of ADAM17 alleviates doxorubicin-induced cardiomyopathy via inhibiting TNFα-TRAF3-TAK1-MAPK axis[J]. Signal Transduct Target Ther, 2024, 9(1):273.DOI:10.1038/s41392-024-01977-z. Cited in this article [1]

[8]	耿洁, 刘洁婕, 刘亚, 等. 上调miR-21-5p对阿霉素诱导的心肌细胞增殖、凋亡的影响及其机制研究[J]. 广西医科大学学报, 2024, 41(5):722-727.DOI:10.16190/j.cnki.45-1211/r.2024.05.012. Cited in this article [1]

[9]	Chen S, Chen J, Du W, et al. PDE10A inactivation prevents doxorubicin-induced cardiotoxicity and tumor growth[J]. Circ Res, 2023, 133(2):138-157.DOI:10.1161/CIRCRESAHA.122.322264. Cited in this article [1]

[10]	Yu P, Zhang X, Liu N, et al. Pyroptosis:mechanisms and diseases[J]. Signal Transduct Target Ther, 2021, 6(1):128.DOI:10.1038/s41392-021-00507-5. Cited in this article [1]

[11]	Zeng C, Duan F, Hu J, et al. NLRP3 inflammasome-mediated pyroptosis contributes to the pathogenesis of non-ischemic dilated cardiomyopathy[J]. Redox Biol, 2020, 34:101523.DOI:10.1016/j.redox.2020.101523. Cited in this article [1]

[12]	Wei X, Xie F, Zhou X, et al. Role of pyroptosis in inflammation and cancer[J]. Cell Mol Immunol, 2022, 19(9):971-992.DOI:10.1038/s41423-022-00905-x. Cited in this article [1]

[13]	Zhong Z, Gao Y, Zhou J, et al. Inhibiting mir-34a-5p regulates doxorubicin-induced autophagy disorder and alleviates myocardial pyroptosis by targeting Sirt3-AMPK pathway[J]. Biomed Pharmacother, 2023, 168:115654.DOI:10.1016/j.biopha.2023.115654. Cited in this article [2]

[14]	施佳君, 杨钦钦, 富丹婷, 等. 冠心宁片抑制NLRP3/ASC/Caspase-1通路改善阿霉素诱导的扩张型心肌病大鼠心肌细胞焦亡[J]. 中国实验动物学报, 2024, 32(3):337-346.DOI:10.3969/j.issn.1005-4847.2024.03.007. Cited in this article [1]

[15]	熊凤梅, 刘瑞萍, 李洋, 等. 和厚朴酚可体外减轻阿霉素诱导的心肌毒性:基于激活 AMPK/Nrf2 信号通路抑制细胞焦亡[J]. 南方医科大学学报, 2022, 42(8):1205-1211.DOI:10.12122/j.issn.1673-4254.2022.08.13. Cited in this article [1]

[16]	Xiao B, Hong L, Cai X, et al. The true colors of autophagy in doxorubicin induced cardiotoxicity[J]. Oncol Lett, 2019, 18(3):2165-2172.DOI:10.3892/ol.2019.10576. Cited in this article [1]

[17]	Peng K, Zeng C, Gao Y, et al. Overexpressed SIRT6 ameliorates doxorubicin-induced cardiotoxicity and potentiates the therapeutic efficacy through metabolic remodeling[J]. Acta Pharm Sin B, 2023, 13(6):2680-2700.DOI:10.1016/j.apsb.2023.03.019. Cited in this article [2]

[18]	Nakagama S, Maejima Y, Fan Q, et al. Endoplasmic reticulum selective autophagy alleviates anthracycline-induced cardiotoxicity[J]. JACC CardioOncol, 2023, 5(5):656-670.DOI:10.1016/j.jaccao.2023.05.009. Cited in this article [1]

[19]

Pan JA, Zhang H, Lin H, et al. Irisin ameliorates doxorubicin-induced cardiac perivascular fibrosis through inhibiting endothelial-to-mesenchymal transition by regulating ROS accumulation and autophagy disorder in endothelial cells[J]. Redox Biol, 2021, 46:102120.DOI:10.1016/j.redox.2021.102120. Cited in this article [1]

[20]	Yi X, Wang Q, Zhang M, et al. Ferroptosis:a novel therapeutic target of natural products against doxorubicin-induced cardiotoxicity[J]. Biomed Pharmacother, 2024, 178:117217.DOI:10.1016/j.biopha.2024.117217. Cited in this article [1]

[21]	Yu W, Hu Y, Liu Z, et al. Sorting nexin 3 exacerbates doxorubicin-induced cardiomyopathy via regulation of TFRC-dependent ferroptosis[J]. Acta Pharm Sin B, 2023, 13(12):4875-4892.DOI:10.1016/j.apsb.2023.08.016. Cited in this article [1]

[22]	Qiu H, Huang S, Liu Y, et al. Idebenone alleviates doxorubicin-induced cardiotoxicity by stabilizing FSP1 to inhibit ferroptosis[J]. Acta Pharm Sin B, 2024, 14(6):2581-2597.DOI:10.1016/j.apsb.2024.03.015.E. Cited in this article [1]

[23]	Huang C, Guo Y, Li T, et al. Pharmacological activation of GPX4 ameliorates doxorubicin-induced cardiomyopathy[J]. Redox Biol, 2024, 70:103024.DOI:10.1016/j.redox.2023.103024. Cited in this article [1]

[24]	Wu L, Du Y, Wang L, et al. Inhibition of METTL3 ameliorates doxorubicin-induced cardiotoxicity through suppression of TFRC-mediated ferroptosis[J]. Redox Biol, 2024, 72:103157.DOI:10.1016/j.redox.2024.103157. Cited in this article [1]

[25]	Cui J, Chen Y, Yang Q, et al. Protosappanin A protects DOX-induced myocardial injury and cardiac dysfunction by targeting ACSL4/FTH1 axis-dependent ferroptosis[J]. Adv Sci(Weinh), 2024, 11(34):e2310227.DOI:10.1002/advs.202310227. Cited in this article [2]

[26]	Luo W, Zou X, Wang Y, et al. Critical role of the cGAS-STING pathway in doxorubicin-induced cardiotoxicity[J]. Circ Res, 2023, 132(11):e223-e242.DOI:10.1161/CIRCRESAHA.122.321587. Cited in this article [2]

[27]	李润琦, 翟志红, 杜晴晴, 等. TBHQ对阿霉素慢性心脏毒性大鼠的保护作用[J]. 山西医科大学学报, 2024, 55(7):835-841.DOI:10.13753/j.issn.1007-6611.2024.07.004. Cited in this article [1]

[28]	Dabour MS, Abdelgawad IY, Sadaf B, et al. Losmapimod ameliorates doxorubicin-induced cardiotoxicity through attenuating senescence and inflammatory pathways[J]. Biomed Pharmacother, 2024, 179:117288.DOI:10.1016/j.biopha.2024.117288. Cited in this article [1]

[29]	Alwaili MA, Abu-Almakarem AS, El-Said KS, et al. Shikimic acid protects against doxorubicin-induced cardiotoxicity in rats[J]. Sci Rep, 2025, 15(1):8126.DOI:10.1038/s41598-025-90549-4. Cited in this article [1]

[30]	Chen C, Jiang L, Zhang M, et al. Isodunnianol alleviates doxorubicin-induced myocardial injury by activating protective autophagy[J]. Food Funct, 2019, 10(5):2651-2657.DOI:10.1039/c9fo00063a. Cited in this article [1]

[31]	Cheng Y, Wu X, Nie X, et al. Natural compound glycyrrhetinic acid protects against doxorubicin-induced cardiotoxicity by activating the Nrf2/HO-1 signaling pathway[J]. Phytomedicine, 2022, 106:154407.DOI:10.1016/j.phymed.2022.154407. Cited in this article [1]

[32]	陈鹏, 刘石琳, 朱小蕾, 等. 基于FGF2表达探讨红景天苷对阿霉素诱导的心脏毒性的保护作用及对NLRP3炎症小体的影响[J]. 现代中西医结合杂志, 2024, 33(13):1794-1800,1806.DOI:10.3969/j.issn.1008-8849.2024.13.008. Cited in this article [1]

[33]	李银萍, 宣悦, 廖玮嫣, 等. 葛根素通过AMPK/ASMase激活自噬减轻阿霉素诱导的心肌细胞毒性[J]. 中药新药与临床药理, 2024, 35(10):1520-1530.DOI:10.19378/j.issn.1003-9783.2024.10.009. Cited in this article [1]

[34]	陈榕榕, 郑平, 李得清, 等. 益气化瘀汤调控miR-532-3p改善阿霉素心脏毒性的机制研究[J]. 中国中医药信息杂志, 2025, 32(1):128-133.DOI:10.19879/j.cnki.1005-5304.202403652. Cited in this article [1]

[35]	Kanwal U, Irfan Bukhari N, Ovais M, et al. Advances in nano-delivery systems for doxorubicin:an updated insight[J]. J Drug Target, 2018, 26(4):296-310.DOI:10.1080/1061186X.2017.1380655. Cited in this article [1]

[36]	彭凤丽, 李朝富, 石蓓. 纳米囊泡递送系统在心血管疾病中的应用[J]. 中国组织工程研究, 2023, 27(30):4862-4868.DOI:10.12307/2023.470. Cited in this article [1]

[37]

Yarana C, Siwaponanan P, Maneechote C, et al. Extracellular vesicles released after doxorubicin treatment in rats protect cardiomyocytes from oxidative damage and induce pro-inflammatory gene expression in macrophages[J]. Int J Mol Sci, 2022, 23(21):13465.DOI:10.3390/ijms232113465. Cited in this article [1]

[38]	O’Brien CG, Ozen MO, Ikeda G, et al. Mitochondria-rich extracellular vesicles rescue patient-specific cardiomyocytes from doxorubicin injury:insights into the SENECA trial[J]. JACC CardioOncol, 2021, 3(3):428-440.DOI:10.1016/j.jaccao.2021.05.006. Cited in this article [1]

[39]	Beaumier A, Robinson SR, Robinson N, et al. Extracellular vesicular microRNAs as potential biomarker for early detection of doxorubicin-induced cardiotoxicity[J]. J Vet Intern Med, 2020, 34(3):1260-1271.DOI:10.1111/jvim.15762. Cited in this article [1]

[40]	赵荫涛, 杨莹莹, 张相钦, 等. 卵泡抑素样蛋白1对阿霉素所致小鼠急性心肌损伤的改善作用及其机制[J]. 吉林大学学报(医学版), 2023, 49(3):565-572.DOI:10.13481/j.1671-587X.20230303. Cited in this article [1]

[41]	卢维哲, 刘海琼, 杨涵滟, 等. MG53蛋白对小鼠阿霉素急性心肌毒性的影响及机制[J]. 中山大学学报(医学科学版), 2023, 44(1):34-43.DOI:10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).20221208.001. Cited in this article [1]

[42]	Sheibani M, Nezamoleslami S, Faghir-Ghanesefat H, et al. Cardioprotective effects of dapsone against doxorubicin-induced cardiotoxicity in rats[J]. Cancer Chemother Pharmacol, 2020, 85(3):563-571.DOI:10.1007/s00280-019-04019-6. Cited in this article [1]

[43]	Eisvand F, Imenshahidi M, Ghasemzadeh Rahbardar M, et al. Cardioprotective effects of alpha-mangostin on doxorubicin-induced cardiotoxicity in rats[J]. Phytother Res, 2022, 36(1):506-524.DOI:10.1002/ptr.7356. Cited in this article [1]

[44]	de Barros JC, Pereira AG, Rodrigues MA, et al. Effects of omega 3 on doxorubicin-induced cardiotoxicity in an experimental rabbit model[J]. Res Socie Devel, 2021, 10:e60101320993.DOI:10.33448/rsd-v10i13.20993. Cited in this article [1]

[45]	Ge W, Zhang X, Lin J, et al. Rnd3 protects against doxorubicin-induced cardiotoxicity through inhibition of PANoptosis in a Rock1/Drp1/mitochondrial fission-dependent manner[J]. Cell Death Dis, 2025, 16(1):2.DOI:10.1038/s41419-024-07322-0. Cited in this article [1]

[46]	Wu L, Wang LT, Du YX, et al. Asiatic acid ameliorates doxorubicin-induced cardiotoxicity by promoting FPN-mediated iron export and inhibiting ferroptosis[J]. Acta Pharmacol Sin, 2025, 46(1):81-95.DOI:10.1038/s41401-024-01367-9. Cited in this article [1]

[47]	Kuno A, Hosoda R, Tsukamoto M, et al. SIRT1 in the cardiomyocyte counteracts doxorubicin-induced cardiotoxicity via regulating histone H2AX[J]. Cardiovasc Res, 2023, 118(17):3360-3373.DOI:10.1093/cvr/cvac026. Cited in this article [1]

[48]

Qaed E, Almoiliqy M, Liu W, et al. Protective effects of phosphocreatine against Doxorubicin-Induced cardiotoxicity through mitochondrial function enhancement and apoptosis suppression via AMPK/PGC-1α signaling pathway[J]. Int Immunopharmacol, 2025, 144:113677.DOI:10.1016/j.intimp.2024.113677. Cited in this article [1]

[49]	He ML, Li XY, Guo YQ, et al. Nerol attenuates doxorubicin-induced heart failure by inhibiting cardiomyocyte apoptosis in rats[J]. Eur J Pharmacol, 2025, 987:177203.DOI:10.1016/j.ejphar.2024.177203. Cited in this article [1]

[50]	Romão PVM, Palozi RAC, Guarnier LP, et al. Cardioprotective effects of Plinia cauliflora(Mart.)Kausel in a rabbit model of doxorubicin-induced heart failure[J]. J Ethnopharmacol, 2019, 242:112042.DOI:10.1016/j.jep.2019.112042. Cited in this article [2]

[51]	张冬, 朱瑾彦, 张敏, 等. 扩张型心肌病动物模型的建立与评估[J]. 实验动物科学, 2023, 40(4):55-61.DOI:10.3969/j.issn.1006-6179.2023.04.011. Cited in this article [1]